FR2925330B1 - Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines - Google Patents

Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines

Info

Publication number
FR2925330B1
FR2925330B1 FR0708983A FR0708983A FR2925330B1 FR 2925330 B1 FR2925330 B1 FR 2925330B1 FR 0708983 A FR0708983 A FR 0708983A FR 0708983 A FR0708983 A FR 0708983A FR 2925330 B1 FR2925330 B1 FR 2925330B1
Authority
FR
France
Prior art keywords
hydrolysat
potato
active ingredient
aquaporin synthesis
activator active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0708983A
Other languages
English (en)
Other versions
FR2925330A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincience SA filed Critical Vincience SA
Priority to FR0708983A priority Critical patent/FR2925330B1/fr
Publication of FR2925330A1 publication Critical patent/FR2925330A1/fr
Application granted granted Critical
Publication of FR2925330B1 publication Critical patent/FR2925330B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
FR0708983A 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines Expired - Fee Related FR2925330B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0708983A FR2925330B1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0708983A FR2925330B1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines

Publications (2)

Publication Number Publication Date
FR2925330A1 FR2925330A1 (fr) 2009-06-26
FR2925330B1 true FR2925330B1 (fr) 2010-04-09

Family

ID=39687045

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0708983A Expired - Fee Related FR2925330B1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines

Country Status (1)

Country Link
FR (1) FR2925330B1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940291B1 (fr) 2008-12-23 2012-12-21 Isp Investments Inc Peptide derive d'hmg-coa reductase et composition cosmetique ou pharmaceutique le contenant
FR2940125B1 (fr) 2008-12-23 2013-03-22 Isp Investments Inc Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase
FR2944445B1 (fr) 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
FR2944526B1 (fr) * 2009-04-15 2013-05-10 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
US8933036B2 (en) 2009-04-15 2015-01-13 Isp Investments Inc. Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair
FR2944527B1 (fr) * 2009-04-15 2013-05-10 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
FR2944446B1 (fr) * 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
ES2396815B1 (es) 2011-05-23 2014-01-20 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención y usos de vesículas de membrana plasmática extraídas de plantas enriquecidas en proteínas transportadoras de membrana.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771632B1 (fr) * 1997-12-01 2000-03-17 Seppic Sa Composition synergique comprenant au moins un lipoaminoacide et au moins un glycol; application en cosmetique
DE10061419A1 (de) * 2000-12-09 2002-06-13 Henkel Kgaa Neue Verwendung von Proteinhydrolysaten
DE10220867A1 (de) * 2002-05-10 2003-11-20 Henkel Kgaa Kosmetische Zusammensetzungen mit einem Silicon-Elastomer und einem verdickenden Polymerlatex
US7429391B2 (en) * 2004-01-30 2008-09-30 Access Business Group International Llc Holistic composition and method for reducing skin pigmentation
FR2900048B1 (fr) * 2006-04-21 2012-11-16 Oreal Compositions comprenant un derive diphenyl-methane hydroxyle
FR2909552B1 (fr) * 2006-12-12 2009-11-20 Oreal Utilisation cosmetique de l'acide anisique pour favoriser la desquamation

Also Published As

Publication number Publication date
FR2925330A1 (fr) 2009-06-26

Similar Documents

Publication Publication Date Title
FR2925326B1 (fr) Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines
FR2925330B1 (fr) Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines
FR2925332B1 (fr) Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines
FR2925329B1 (fr) Utilisation d'un hydrolysat d'avoine en tant que principe actif activateur de la synthese des aquaporines
FR2925325B1 (fr) Utilisation d'un hydrolysat de colza en tant que principe actif activateur de la synthese des aquaporines
CL2008002694A1 (es) Combinaciones de principios activos que contienen derivados de acido tetramico sustituido con espirocetal; uso de las combinaciones para combatir plagas animales.
EA201070698A1 (ru) Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
DE602007010269D1 (de) Synthese von acylaminoalkenylenamiden als substanz-p-antagonisten
TR201902218T4 (tr) Fluopiram içeren aktif madde kombinasyonları.
TR201907575T4 (tr) Hayvan parazitlerini kontrol etmeye yönelik faydalı ajanlar olarak aminobenzamid türevleri.
UY29575A1 (es) Formas polimórficas del éster etílico del ácido 3-((2-((4-(hexiloxicarbonilamino--imino-metil)-fenilamino)-metil)-1-metil-h-bencimidazol-5-carbonil)-piridin-2-il- -amino)-propiónico
EA201290078A1 (ru) Гетероциклические соединения для ингибирования pask
ECSP099648A (es) Derivados de aril isoxazolina insecticidas
UA106875C2 (uk) Тіадіазолілоксифеніламідини та їх застосування як фунгіцидів
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
DE602005022110D1 (de) Synthese und verwendungen von 2-oxo-4-methylthiobuttersäure, deren salze und deren derivate
DOP2011000134A (es) Lactamas como inhibidores de beta secretasa
CL2007003735A1 (es) Compuestos derivados de pirimidinilpirazoles; procedimiento para la sintesis de dichos compuestos; uso de dichos compuestos; procedimiento para combatir plagas animales; y procedimiento para la preparacion de composiciones agroquimicas.
ATE500249T1 (de) Synthese von himbacinanaloga
FR2925331B1 (fr) Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines
BRPI0813926A2 (pt) Utilização de uma substância, composição e métodos de triagem de princípios ativos que inibem a formação dos ages e de cuidado cosmético.
FR2915683B1 (fr) Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
GT200800302A (es) Compuestos de 1-(azolin-2-il)-amino-2-aril-1-heteroaril-etano sustituidos.
FR2930729B1 (fr) Utilisation cosmetique d'un actif issu d'ophiopogon japonicus

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150831